Demeclocycline
| Clinical data | |
|---|---|
| Trade names | Declomycin | 
| Other names | RP-10192, demethylchlortetracycline | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a682103 | 
| Routes of administration | Oral | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Bioavailability | 60–80% | 
| Protein binding | 41–50% | 
| Metabolism | Hepatic | 
| Elimination half-life | 10–17 hours | 
| Excretion | Renal | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.004.396 | 
| Chemical and physical data | |
| Formula | C21H21ClN2O8 | 
| Molar mass | 464.86 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
Demeclocycline (INN, BAN, USAN, brand name Declomycin) is a tetracycline antibiotic which was derived from a mutant strain of Streptomyces aureofaciens.